Table 2.
VCT | SCT | TCT | SCS | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
n=38 | Mean Thickness (µm) |
SE | ICC (95% CI) |
Mean Thickness (µm) |
SE | ICC (95% CI) |
Mean Thickness (µm) |
SE | ICC (95%CI) |
Mean Thickness (µm) |
SE |
Suprachoroidal CLS-TA + Intravitreal Aflibercept (combination arm) | |||||||||||
Baseline | 230.10 | 23.41 | 0.94 (0.85–0.97) | 258.80 | 24.37 | 0.99 (0.99–1.00) | 268.00 | 24.66 | 0.99 (0.99–1.00) | 9.27 | 2.91 |
Month 1 | 216.60 | 17.79 | 250.00 | 18.73 | 263.00 | 18.93 | 13.03 | 3.23 | |||
Month 2 | 215.10 | 17.46 | 249.80 | 18.69 | 263.50 | 18.67 | 13.69 | 3.28 | |||
Month 3 | 218.80 | 18.79 | 253.60 | 20.70 | 267.00 | 20.65 | 13.43 | 3.20 | |||
Intravitreal Aflibercept only (monotherapy arm) | |||||||||||
Baseline | 208.50 | 15.00 | 0.94 (0.85–0.97) | 233.50 | 14.79 | 0.99 (0.99–1.00) | 238.70 | 14.51 | 0.99 (0.99–1.00) | 5.15 | 1.63 |
Month 1 | 200.00 | 19.09 | 229.80 | 18.11 | 235.30 | 17.51 | 5.49 | 1.25 | |||
Month 2 | 196.40 | 18.32 | 222.30 | 17.49 | 229.40 | 16.54 | 6.71 | 1.97 | |||
Month 3 | 186.90 | 15.79 | 218.10 | 17.01 | 223.40 | 16.56 | 5.32 | 1.62 |
Abbreviations: VCT, vascular choroidal thickness; SCT, stromal choroidal thickness; TCT, total choroidal thickness; SCS, suprachoroidal space thickness; IVT, intravitreal; CLS-TA, preservative-free, terminally sterilized triamcinolone acetonide; n, number; SE, standard error; ICC, intra class correlation coefficient